Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relative Bioavailability of Sitravatinib Capsule Formulations in Healthy Subjects
NCT04472650Phase 1Completed
- Sponsor
- BeiGene
- Start
- Jul 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sitravatinib in solid tumor (2 arms), sponsored by BeiGene. Primary endpoints: Area Under the Concentration-time Curve From Time Zero to Infinity, Area Under the Concentration-time Curve From Time Zero to Time of Last Quantifiable Concentration and 5 more. Started Jul 2020; status: completed.
02
Drugs
sitravatinib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04472650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04472650.